Letermovir for cytomegalovirus prophylaxis after allogeneic hematopoietic stem cell transplantation in acute leukemia patients: results of the LETreal study
Yi Xia, Qi Wen, Jing Liu, Jinfang Zhao, Xiaohui Zhang, Lanping Xu, Yu Wang, Yuhong Chen, Yuanyuan Zhang, Yuqian Sun, Yifei Cheng, Yao Chen, Wei Han, Fengrong Wang, Jingzhi Wang, Jun Kong, Leqing Cao, Daoxing Deng, Xiaojun Huang, Xiaodong Mo · 2026
Read Letermovir for cytomegalovirus prophylaxis after allogeneic hematopoietic stem cell transplantation in acute leukemia patients: results of the LETreal study by Yi Xia, Qi Wen, Jing Liu, Jinfang Zhao, Xiaohui Zhang, Lanping Xu, Yu Wang, Yuhong Chen, Yuanyuan Zhang, Yuqian Sun, Yifei Cheng, Yao Chen, Wei Han, Fengrong Wang, Jingzhi Wang, Jun Kong, Leqing Cao, Daoxing Deng, Xiaojun Huang, Xiaodong Mo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13581788.txt.
Description
Yi Xia and co-authors read, in a 2026 study, how a shield drug fares in a big set of blood graft patients. The drug, letermovir, guards graft hosts from cytomegalovirus, a germ that can kill in that state. The set held 1,331 acute leukemia patients with grafts from kin or matched blood. Of them, 978 got the drug and 353 did not. A match path set the two groups even on base traits. In the drug group, grave germ rise by day 100 sat at 7.1 percent. Kids in that group ran a high rate than grown folk.
No trait stood as a lone risk for the day-100 mark in the math. Rates for days 100 to 200 are read in the same frame.
Catalog record
| CREATOR | Yi Xia, Qi Wen, Jing Liu, Jinfang Zhao, Xiaohui Zhang, Lanping Xu, Yu Wang, Yuhong Chen, Yuanyuan Zhang, Yuqian Sun, Yifei Cheng, Yao Chen, Wei Han, Fengrong Wang, Jingzhi Wang, Jun Kong, Leqing Cao, Daoxing Deng, Xiaojun Huang, Xiaodong Mo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |